# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The top 10 large-cap stocks in the last week were RIVN, CUK, FDX, IOT, SUZ, CVNA, FTAI, RDDT, MDB, and ALNY. Many analysts have...
UBS analyst Eliana Merle maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $253 to...
RBC Capital analyst Luca Issi maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target ...
Stifel analyst Paul Matteis maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $215...
Citigroup analyst David Lebovitz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from...
B of A Securities maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $248 to $295.
Leerink Partners maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $138 ...